Alvaro Torres: #healthinsurance that pays for your #medicalcannabis & International Opportunities

Khiron is taking a different approach than US Cannabis companies. They are building data systems to provide evidence-based research to reduce stigma, adopt normalization, and convert opioid users to medical cannabis. Their systems and achievement have quickly led to many breakthroughs, as recently announced, "Khiron signs deal with Bogota's largest public health insurance for medical cannabis coverage." Now that Columbia is on board, Khiron has its eyes on disrupting other international medical markets by taking the data-based evidence to Brazil, Peru, Mexico, and many others This week on The Dime, we host Alvaro Torres, CEO of Khiron, to discuss: •Providing data-based evidence to influence regulators •International challenges & opportunities •Building foundational systems for personalized medicine •How US Cannabis companies are looking to replicate Khiron's international success •and so much more Chapters: 00:00:00 - The Real Competitor to Medical Cannabis and Global Cannabis Industry Perspectives 00:02:39 - Overcoming Hesitation in the Cannabis Industry 00:05:23 - Medical Cannabis and the Future of Healthcare in Colombia with Chiron's David Kaplan 00:08:03 - Building Demand in the Cannabis Industry 00:10:41 - The Necessary Steps to Develop an Industry 00:13:16 - Bringing High-Quality Medical Services to Underserved Populations 00:16:08 - Integrative Care and Insurance Validation 00:18:44 - Building a Data-Driven Cannabis Industry 00:21:29 - Responsibility and Winding Down Operations 00:24:07 - Chiron's Assets in Europe: People, Data, and Virtual Clinics 00:26:40 - Seamless Transfer of Cannabis Research Data Across Cultures and Countries 00:29:28 - Solving problems and understanding patient needs in the cannabis industry 00:32:07 - Challenges of Exporting Cannabis Products Across Countries 00:34:46 - Evaluating the Cannabis Market in Comparison to the US 00:37:20 - Potential Synergies and Alliances in Medical Cannabis Industry 00:40:04 - From Cannabis to Healthcare Data: The Transition 00:42:48 - The Language of Data and Patience in the Cannabis Industry 00:45:31 - Optimism vs Realism in the Cannabis Industry 00:48:19 - The Importance of Listening to Advice and Following Your Gut 00:51:09 - The Future of Global Cannabis Legalization 00:53:57 - The Need for the US to Lead Global Cannabis Legalization 00:56:41 - Accelerating the Cannabis Industry 00:59:11 - Excitement about the Colombian news media industry's growth About Khiron A GLOBAL MEDICAL CANNABIS COMPANY IMPROVING THE QUALITY OF PEOPLES' LIVES. We believe in the benefits of medical cannabis to improve people's quality of life through the development of high-quality pharmaceutical products, continuous medical education for health professionals, and permanent monitoring of the patient in their treatment, through the Patient Follow-up Program. #cannabisinsider #KHRN #GlobalCannabis TSXV: KHRN | OTCQX: KHRNF #cannnabisinsider #internationalcannabis #KHRNF Khiron Links: https://khiron.ca/ https://twitter.com/khironlife https://www.instagram.com/khironlife/?hl=en https://www.linkedin.com/in/alvaroftorres/?originalSubdomain=co https://twitter.com/alvarotorresrue Follow us: Our Links. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. 8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here: https://www.8threv.com/monthly-report/ 🎥 YouTube: The Dime 📸 Instagram: The Dime 🐣 Twitter: Bryan Fields, Kellan Finney 🎙 The Dime Podcast: https://the-dime-177afd40.simplecast.com/

Chapters

1. 0:00The Real Competitor to Medical Cannabis and Global Cannabis Industry Perspectives
2. 2:39Overcoming Hesitation in the Cannabis Industry
3. 5:23Medical Cannabis and the Future of Healthcare in Colombia with Chiron's David Kaplan
4. 8:03Building Demand in the Cannabis Industry
5. 10:41The Necessary Steps to Develop an Industry
6. 13:16Bringing High-Quality Medical Services to Underserved Populations
7. 16:08Integrative Care and Insurance Validation
8. 18:44Building a Data-Driven Cannabis Industry
9. 21:29Responsibility and Winding Down Operations
10. 24:07Chiron's Assets in Europe: People, Data, and Virtual Clinics
11. 26:40Seamless Transfer of Cannabis Research Data Across Cultures and Countries
12. 29:28Solving problems and understanding patient needs in the cannabis industry
13. 32:07Challenges of Exporting Cannabis Products Across Countries
14. 34:46Evaluating the Cannabis Market in Comparison to the US
15. 37:20Potential Synergies and Alliances in Medical Cannabis Industry
16. 40:04From Cannabis to Healthcare Data: The Transition
17. 42:48The Language of Data and Patience in the Cannabis Industry
18. 45:31Optimism vs Realism in the Cannabis Industry
19. 48:19The Importance of Listening to Advice and Following Your Gut
20. 51:09The Future of Global Cannabis Legalization
21. 53:57The Need for the US to Lead Global Cannabis Legalization
22. 56:41Accelerating the Cannabis Industry
23. 59:11Excitement about the Colombian news media industry's growth